Vladimir V. Klimachev

Vladimir V. Klimachev

Auto-generated profile, based on publicly available information

Vladimir V. Klimachev

Altai State Medical University

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2012 in Sarcoma
Verified
Journal Article
Open access
PDF file
AAAshot Avdalyan
Ashot Avdalyan
IBIgor Bobrov
Igor Bobrov
VKVladimir Klimachev
Vladimir Klimachev
ALAlexander Lazarev
Alexander Lazarev
The objective of this study was to investigate the prognostic value of microvessel density (MVD) in uterine leiomyosarcoma (LMS) and peritumoral area (PA) as evaluated by CD31 expression and argyrophilic nucleolar organizer region (AgNOR) count in endothelial cells. Tissue specimens from 66 patients with uterine LMS were examined. There were no significant differences in the mean MVD between tumor itself and the PA (𝑃=0.9); moreover, the MVD in the PA often exceeded that in the tumor. No correlation or significant differences were also found in the MVD between different grades of malignancy of LMS (𝑟=0.1; 𝑃=0.07). The number of AgNORs in tumor endothelial cells was significantly higher in tumor vessels than in the peritumoral area (𝑃<0.005) and increased with the tumor grade. Analysis of the prognostic value of MVD in uterine LMS and PA showed that the density of tumor vessels was not an independent criterion, while the MVD in the PA affected 10-year survival to a significantly greater extent (𝜒2=27.5; 𝑃=0.0003). The number of AgNORs also had an important effect on survival of LMS patients: when the threshold of 11.6 granules was exceeded, prognosis was significantly more unfavorable than that prior to exceeding the threshold.

1 January 2011
Verified
Journal Article
Closed access
VKV V Klimachev
V V Klimachev
ANA I Neĭmark
A I Neĭmark
VGV Ia Gerval'D
V Ia Gerval'D
IBI P Bobrov
I P Bobrov
AAA M Avdalian
A M Avdalian
TCT M Cherdantseva
T M Cherdantseva

6 October 2022 in Russian Journal of Oncology
Verified
Journal Article
Open access
PDF file
IBIgor P. Bobrov
Igor P. Bobrov
ALAlexander F. Lazarev
Alexander F. Lazarev
TCTatyana M. Cherdantseva
Tatyana M. Cherdantseva
IKIlya V. Klimachev
Ilya V. Klimachev
VKVladimir V. Klimachev
Vladimir V. Klimachev
МНМяделец Михаил Николаевич
Мяделец Михаил Николаевич
AIM: To quantitatively analyze the macrophage distribution density (MF) of the peritumoral zone (PZ) of clear cell renal cell carcinoma (CCRCC) and determine the relationship of MF distribution density in PZ with clinical and morphological prognostic variables and postoperative survival of patients. MATERIALS AND METHODS: The study included 52 patients with CCRCC, who had an average age of 56.70.8 years. Using monoclonal mouse antibodies for CD68 (clone PG-M1, DAKO), using an immunohistochemical method, macrophages were identified in the paraffin sections. The average amount of MF in the PZ was determined in three fields of view at 400 magnification. For the PZ, the tissue was taken directly adjacent to the tumor to the conditionally unchanged kidney tissue. RESULTS: The correlation analysis revealed that the density of the MF distribution in the CCRCC was interrelated with the stage of the disease (r=0.66; p=0.0001), size of the tumor node (r=0.52; p=0.0001), degree of anaplasia according to Fuhrman (r=0.80; p=0.0001), presence of metastases (r=0.62; 0.0001), and postoperative survival of patients (r=0.53; p=0.0001). However, there were no correlations with the gender (r=0.007; p=0.62) and age of the patients (r=0.03; p=0.83). With the number of MF in the PP 8.8, the cumulative proportion of survivors by the five-year term was 0.70 (70%). Moreover, when the number of MF in the PZ was 8.8, none of the patients lived to the five-year term, the cumulative proportion of survivors was 0 (log-rank-test, p=0.000001). CONCLUSION: The density of MF distribution in PZ is interrelated with significant clinical and morphological parameters of CCRCC and is a predictor of the prognosis of five-year postoperative survival of patients. Thus, quantitative estimation of the number of MF in the PZ can be used in predicting the course of CCRCC along with the traditional classical forecasting factors.

14 October 2023 in Russian Journal of Oncology
Verified
Journal Article
Closed access
PDF file
IBIgor P. Bobrov
Igor P. Bobrov
ALAlexander F. Lazarev
Alexander F. Lazarev
TCTatyana M. Cherdantseva
Tatyana M. Cherdantseva
IKIlya V. Klimachev
Ilya V. Klimachev
VKVladimir V. Klimachev
Vladimir V. Klimachev
МНМяделец Михаил Николаевич
Мяделец Михаил Николаевич
AIM: To evaluate the prognostic value of quantitative CD8+ T-lymphocyte counts in the peritumorotic zone of renal cell cancer. MATERIAL AND METHODS: The material of 74 patients after operative treatment for renal cell carcinoma with complete 5-year follow-up was retrospectively analyzed. Of the 74 patients, 56 were alive by the 5-year follow-up, and 18 had died of cancer. After immunohistochemical staining, CD8+ T-lymphocyte distribution density in the peritumorotic zone of carcinomas was determined in 3 representative fields of view at 400 magnification and correlated with the clinicopathological characteristics of neoplasms and overall 5-year patient survival rate. RESULTS: The high level of CD8+ T-lymphocyte infiltration in the peritumoral zone of carcinomas was seen in stages IIIIV of the disease (p=0.0000001), in tumors 7 cm (p=0.0000001), in Fuhrman grade IIIIV anaplasia (p=0.001), in metastases (p=0.0000001) and in the shorter total survival rate of patients (p=0.0003). High CD8+ T-lymphocyte count was also observed in men (p=0.001) and in cases of unclassified cancer. CONCLUSION: In the light of the need to search for new prognostic criteria in renal cancer, we conclude that a high level of peritumorous zone infiltration by CD8+ T-lymphocytes is an unfavorable prognostic factor. Assessment of peritumorous zone infiltration by CD8+ T-lymphocytes may serve as an additional prognostic factor in renal cell carcinoma.

13 July 2006
Verified
Journal Article
Closed access
ALA F Lazarev
A F Lazarev
VKV V Klimachev
V V Klimachev
AAA M Avdalian
A M Avdalian
IBI P Bobrov
I P Bobrov
VZV T Zor'Kin
V T Zor'Kin

30 August 2008
Verified
Journal Article
Closed access
IBI P Bobrov
I P Bobrov
AAA M Avdalian
A M Avdalian
ALA F Lazarev
A F Lazarev
VKV V Klimachev
V V Klimachev
TKT B Klimacheva
T B Klimacheva
EME V Mishchenko
E V Mishchenko